Johnson and Johnson files EU notification and extends DePuy offer:
This article was originally published in Clinica
Johnson & Johnson has filed the required notification relating to its proposed $3.5 billion takeover of orthopaedics company DePuy with the European Commission. At the same time, it has extended its tender offer for the Roche subsidiary to October 16. The Commission has a month to complete its preliminary examination and determine whether it needs to investigate the proposed deal further. As clearance under EU merger control regulations would not be obtained before the scheduled expiry date for the offer of October 5, J&J and DePuy agreed to the extend the offer. If the deal goes through, J&J would also gain ownership of the spinal implant company, AcroMed, which DePuy recently acquired.